Clinical Trials

VALOR trial aims to discover the optimal treatment for stage 1 lung cancer

A UCLA HemOnc Fellow is determined to reduce cancer disparities

The first participant in the trial not only decreased his daily insulin use by 91%, but for the first time in his life, his body is producing insulin in response to blood sugar fluctuation

What makes this parasomnia so frightening?

Groundbreaking science and cross-specialty collaboration enable transplant recipients to thrive without immunosuppressive drugs

‘It is a recognition of the scholarly environment and infrastructure we have built to enable and foster outstanding scientific research,’ says David Geffen School of Medicine Dean Kelsey Martin

Laurie Adami participated in the trial for the immunotherapy treatment, which received FDA approval March 5

Parton knew he needed extraordinary measures to beat the disease: the cancer was spreading all over his body. That’s when he met with Dr. Edward Garon of the UCLA's Jonsson Comprehensive Cancer Center